<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Abbott Hall | Activity</title>
	<link>https://www.catswannabecats.com/members/pajamaicon08/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/pajamaicon08/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Abbott Hall.</description>
	<lastBuildDate>Wed, 24 Jun 2026 15:14:21 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ade592698790ef4f87da608158d98103</guid>
				<title>Abbott Hall posted an update: On the other hand, high (increased) OPN immunostaining was [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25498/</link>
				<pubDate>Mon, 09 Jun 2025 07:32:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>On the other hand, high (increased) OPN immunostaining was associated with better overall survival . CONCLUSIONS In endometrial carcinoma, immunohistochemical staining of OPN could be a helpful tool in the prediction survival pattern. OPN immunostaining showed no association with most clinicopathological features. Further investigations both&hellip;<span class="activity-read-more" id="activity-read-more-25498"><a href="https://www.catswannabecats.com/activity/p/25498/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c2b00930b810b0e7973e7909241e854d</guid>
				<title>Abbott Hall posted an update: Cyclodextrin (CD)-based polymers are known to efficiently [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20735/</link>
				<pubDate>Fri, 06 Jun 2025 07:19:26 -0400</pubDate>

									<content:encoded><![CDATA[<p>Cyclodextrin (CD)-based polymers are known to efficiently form molecular inclusion complexes with various organic and inorganic guest compounds. In addition, they also have a great potential as metal complexes because deprotonated hydroxyls can strongly bind metal ions under alkaline conditions. The range of environmental conditions for&hellip;<span class="activity-read-more" id="activity-read-more-20735"><a href="https://www.catswannabecats.com/activity/p/20735/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">46fe9af31120b5192049e608c67fa674</guid>
				<title>Abbott Hall posted an update: Stereotactic body radiotherapy has emerged as one of the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/9057/</link>
				<pubDate>Sat, 31 May 2025 22:06:10 -0400</pubDate>

									<content:encoded><![CDATA[<p>Stereotactic body radiotherapy has emerged as one of the preferred treatments for patients with spine metastases, with the potential for long-term control from lesion irradiation. Post-treatment vertebral compression fractures are a known complication of this therapy, contributing to worsening pain and reduced quality of life, sometimes requiring&hellip;<span class="activity-read-more" id="activity-read-more-9057"><a href="https://www.catswannabecats.com/activity/p/9057/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ebeecc9aedbc7e26c4e1f45867c93032</guid>
				<title>Abbott Hall became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8865/</link>
				<pubDate>Sat, 31 May 2025 21:48:29 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>